Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Hansa Biopharma
  4. Hansa Biopharma — Februar 2023

Hansa Biopharma — Februar 2023

Planlagt Fastgjort Låst Flyttet Hansa Biopharma
38 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    LP90
    wrote on sidst redigeret af
    #22

    Godmorgen 🙂

    1 Reply Last reply
    0
    • M Offline
      M Offline
      MBCruise
      wrote on sidst redigeret af
      #23

      Kopieret fra Genmab chatten. Nr. 2 er god læsning :-).https://www.fiercepharma.com/marketing/top-10-most-anticipated-drug-launches-2023?itm_source=parsely-api

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #24

        Godmorgen 🙂

        1 Reply Last reply
        0
        • L Offline
          L Offline
          LP90
          wrote on sidst redigeret af
          #25

          Godmorgen 🙂

          1 Reply Last reply
          0
          • A Offline
            A Offline
            Aps_invest
            wrote on sidst redigeret af
            #26

            Hansa virker “forpestet” 🙂 ALLE stigninger bliver omgående neutraliseret af et udsalg. Tålmodighed, men lidt frustrerende at se sælgerne kaste sig over aktien efter lidt stigning. 🙂

            1 Reply Last reply
            0
            • U Offline
              U Offline
              Urban
              wrote on sidst redigeret af
              #27

              Helt enig;-)

              1 Reply Last reply
              0
              • M Offline
                M Offline
                MBCruise
                wrote on sidst redigeret af
                #28

                Interresant artikel med brug af Imlifidase udenfor nyre transplantation. Brugt off-label til en patient med AML (Acute myeloid leukemia). Imlifidase virkede som det skulle (som sædvanligt).https://ashpublications.org/blood/article/140/Supplement 1/8562/489191/Successful-Desensitization-of-Severe-Alloimmune

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  LP90
                  wrote on sidst redigeret af
                  #29

                  Godmorgen 🙂 Aps ja du har ret alle stigninger neutraliseres hurtigt øv

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #30

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #31

                      Hansa Biopharma: Update ahead of 2023 – Gradual progress ahead

                      Just a moment...

                      favicon

                      (www.redeye.se)

                      Redeye updates its outlook on Hansa Biopharma, anticipating gradual launch support during 2023 and supporting pipeline progress over the next 12 months.

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #32

                        We make a slight negative revision after the recent Q4 result, and the most significant change is the number of shares relating to funding protecting the equity levels.
                        Our Base Case is SEK 170 (410) with a Bull Case of SEK 400 (600) and a Bear Case of SEK 45 (175).

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #33

                          (Redeye RESEARCH UPDATE - 2023-02-10)

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            Jazzz
                            wrote on sidst redigeret af
                            #34

                            Selvfølgelig lidt et gok i nødden, men da det jo, ihvertfald indtil nu, ikke har noget at gøre med om det de laver duer, men mere noget med timing, er det for mig at se, blot et realistisk perspektiv.

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              Jazzz
                              wrote on sidst redigeret af
                              #35

                              Fremtiden ser stadig lys ud..

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #36

                                Redeye sänker motiverat värde för Hansa Biopharma till 170 kronor (410)

                                ... "Analyshuset spår att försäljningen av Idefirix kommer att uppgå till 143 miljoner kronor i år och sedan öka till över 900 miljoner kronor år 2026." ...

                                Nyhetsbyrån Finwire

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #37

                                  JA, vi er stadig i starten af S-kurven.

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #38

                                    Hansa Biopharma Automatisk teknisk analys. Medellång sikt, 14 feb 2023 (for dem som er til TA):

                                    Link Preview Image
                                    Hansa Biopharma - teknisk analys av aktien - Dagens industri

                                    Utförlig grafisk information om Hansa Biopharma historiska utveckling som ger en hint om aktiens framtida utveckling.

                                    favicon

                                    Dagens industri (www.di.se)

                                    (Dagens industri)

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      B.Andersen
                                      wrote on sidst redigeret af
                                      #39

                                      "Elisabeth Sonnesson, Global Franchise Lead Autoimmunity presented last week at Erik Pensers Healthcare Day focusing on autoimmune diseases. A very insightful presentation on the autoimmune space and the programs Hansa is currently investigating" https://proinvestor.com/boards/110967

                                      1 Reply Last reply
                                      0

                                      Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                      Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                      With your input, this post could be even better 💗

                                      Tilmeld Log ind
                                      Svar
                                      • Svar som emne
                                      Login for at svare
                                      • Ældste til nyeste
                                      • Nyeste til ældste
                                      • Most Votes


                                      • Log ind

                                      • Har du ikke en konto? Tilmeld

                                      • Login or register to search.
                                      Powered by NodeBB Contributors
                                      • First post
                                        Last post
                                      0
                                      • Kategorier
                                      • Seneste
                                      • Etiketter
                                      • Populære
                                      • Verden
                                      • Bruger
                                      • Grupper